{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:20:17Z","timestamp":1781871617207,"version":"3.54.5"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T00:00:00Z","timestamp":1404777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101481","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T17:35:18Z","timestamp":1404840918000},"page":"e101481","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Functional and Molecular Surveillance of Helicobacter pylori Antibiotic Resistance in Kuala Lumpur"],"prefix":"10.1371","volume":"9","author":[{"given":"Xinsheng","family":"Teh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Ching","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Hwong Ruey","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mun Fai","family":"Loke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamuna","family":"Vadivelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khean Lee","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1128\/CMR.10.4.720","article-title":"<italic>Helicobacter pylori<\/italic>","volume":"10","author":"BE Dunn","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1000544","DOI":"10.1371\/journal.ppat.1000544","article-title":"<italic>Helicobacter pylori<\/italic>&apos;s unconventional role in health and disease","volume":"5","author":"MS Dorer","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref3","unstructured":"WHO (2011) Agents Classified by the IARC Monographs, Volumes 1\u2013102. Cancer, World Health Organization."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2011.00874.x","article-title":"Epidemiology of <italic>Helicobacter pylori<\/italic> infection and public health implications","volume":"16","author":"KL Goh","year":"2011","journal-title":"Helicobacter"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1751-2980.2008.00344.x","article-title":"Changing epidemiology of <italic>Helicobacter pylori<\/italic> in Asia","volume":"9","author":"HJ Tan","year":"2008","journal-title":"Journal of Digestive Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1053\/j.gastro.2009.07.060","article-title":"Early <italic>Helicobacter pylori<\/italic> Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease","volume":"137","author":"CY Wu","year":"2009","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","article-title":"Current European concepts in the management of <italic>Helicobacter pylori<\/italic> infection\u2014the Maastricht Consensus Report. The European <italic>Helicobacter pylori<\/italic> Study Group (EHPSG)","volume":"9","author":"P Malfertheiner","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of <italic>Helicobacter pylori<\/italic> infection-the Maastricht IV\/Florence Consensus Report","volume":"61","author":"P Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/gut.2010.231233","article-title":"Sequential therapy for <italic>Helicobacter pylori<\/italic> eradication: is levofloxacin better?","volume":"60","author":"A Zullo","year":"2011","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for <italic>Helicobacter pylori<\/italic>","volume":"26","author":"L Fischbach","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1756283X11432492","article-title":"The challenge of <italic>Helicobacter pylori<\/italic> resistance to antibiotics: the comeback of bismuth-based quadruple therapy","volume":"5","author":"F Megraud","year":"2012","journal-title":"Therap Adv Gastroenterol"},{"key":"ref12","first-page":"A333","article-title":"Second-line rescue therapy with levofloxacin after H-pylori treatment failure: A Spanish multicenter study","volume":"134","author":"JP Gisbert","year":"2008","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1053\/gast.2002.37051","article-title":"A randomized comparison of quadruple and triple therapies for <italic>Helicobacter pylori<\/italic> eradication: The QUADRATE Study","volume":"123","author":"PH Katelaris","year":"2002","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkr410","article-title":"Antimicrobial susceptibility of <italic>Helicobacter pylori<\/italic> to six antibiotics currently used in Spain","volume":"67","author":"A Cuadrado-Lavin","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1523-5378.2012.00935.x","article-title":"Gemifloxacin Can Partially Overcome Quinolone Resistance of <italic>H. pylori<\/italic> with <italic>gyrA<\/italic> Mutation in Taiwan","volume":"17","author":"WL Chang","year":"2012","journal-title":"Helicobacter"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S881","DOI":"10.1016\/S0016-5085(11)63665-2","article-title":"Mutations of <italic>Helicobacter pylori<\/italic> in Fluoroquinolone Resistance and the Effect of Point Mutation of <italic>gyrA<\/italic> on the Second Line Eradication Therapy in Korea","volume":"140","author":"N Kim","year":"2011","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2011.00912.x","article-title":"Fluoroquinolone Resistance in <italic>Helicobacter pylori<\/italic>: Role of Mutations at Position 87 and 91 of GyrA on the Level of Resistance and Identification of a Resistance Conferring Mutation in GyrB","volume":"17","author":"E Rimbara","year":"2012","journal-title":"Helicobacter"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-9-13","article-title":"Antimicrobial resistance of <italic>H. pylori<\/italic> to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial","volume":"9","author":"J Bago","year":"2010","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1523-5378.2010.00788.x","article-title":"The evolution of <italic>Helicobacter pylori<\/italic> antibiotics resistance over 10 years in Beijing, China","volume":"15","author":"W Gao","year":"2010","journal-title":"Helicobacter"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1751-2980.2010.00445.x","article-title":"Efficacy of 1-week proton pump inhibitor triple therapy as first-line <italic>Helicobacter pylori<\/italic> eradication regime in Asian patients: is it still effective 10 years on?","volume":"11","author":"CS Qua","year":"2010","journal-title":"J Dig Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1523-5378.2010.00816.x","article-title":"Analysis of antibiotic susceptibility patterns of <italic>Helicobacter pylori<\/italic> isolates from Malaysia","volume":"16","author":"N Ahmad","year":"2011","journal-title":"Helicobacter"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3748\/wjg.15.3161","article-title":"Characterization of clarithromycin resistance in Malaysian isolates of <italic>Helicobacter pylori<\/italic>","volume":"15","author":"N Ahmad","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2012.05054.x","article-title":"High-dose rabeprazole\u2013amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for <italic>Helicobacter pylori<\/italic> treatment failures","volume":"35","author":"KL Goh","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1365-2036.2012.05120.x","article-title":"Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate <italic>Helicobacter pylori<\/italic> infection - author&apos;s reply","volume":"35","author":"KL Goh","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"ref25","first-page":"1373","article-title":"Rabeprazole A Review of its Use in the Management of Gastric Acid-Related Diseases in Adults","volume":"69","author":"CM Baldwin","year":"2009","journal-title":"Drugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1523-5378.2011.00841.x","article-title":"High <italic>Helicobacter pylori<\/italic> resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia","volume":"16","author":"KL Goh","year":"2011","journal-title":"Helicobacter"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1751-2980.2010.00423.x","article-title":"Clarithromycin resistance and point mutations in the <italic>23S rRNA<\/italic> gene in <italic>Helicobacter pylori<\/italic> isolates from Malaysia","volume":"11","author":"SL Ho","year":"2010","journal-title":"Journal of Digestive Diseases"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1099\/jmm.0.45701-0","article-title":"Role of the <italic>rdxA<\/italic> and <italic>frxA<\/italic> genes in oxygen-dependent metronidazole resistance of <italic>Helicobacter pylori<\/italic>","volume":"53","author":"MM Gerrits","year":"2004","journal-title":"J Med Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3748\/wjg.v16.i18.2272","article-title":"Distribution of <italic>gyrA<\/italic> mutations in fluoroquinolone-resistant <italic>Helicobacter pylori<\/italic> strains","volume":"16","author":"LH Wang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/AAC.47.12.3942-3944.2003","article-title":"Single and double mutations in <italic>gyrA<\/italic> but not in <italic>gyrB<\/italic> are associated with low- and high-level fluoroquinolone resistance in <italic>Helicobacter pylori<\/italic>","volume":"47","author":"J Tankovic","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","unstructured":"Corry JEL, Curtis GDW, Baird RM (2003) Handbook of culture media for food microbiology. Amsterdam Boston: Elsevier. xiv, 662 p.p."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.resmic.2006.10.001","article-title":"Alterations in <italic>rdxA<\/italic> and <italic>frxA<\/italic> genes and their upstream regions in metronidazole-resistant <italic>Helicobacter pylori<\/italic> isolates","volume":"158","author":"F Han","year":"2007","journal-title":"Res Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1111\/j.1440-1746.2009.06220.x","article-title":"Contribution of efflux pumps to clarithromycin resistance in <italic>Helicobacter pylori<\/italic>","volume":"25","author":"K Hirata","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/jac\/dkq405","article-title":"Isolation and eradication of a clinical isolate of <italic>Helicobacter pylori<\/italic> resistant to five antimicrobials in Germany","volume":"66","author":"N Wuppenhorst","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref35","unstructured":"Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symposium: 95\u201398."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"K Tamura","year":"2011","journal-title":"Mol Biol Evol"},{"key":"ref37","first-page":"262","article-title":"A ten year (1999-2008) retrospective study of amoebiasis in University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia","volume":"26","author":"F Farhana","year":"2009","journal-title":"Tropical Biomedicine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCG.0b013e3182676e2b","article-title":"The incidence of primary antibiotic resistance of <italic>Helicobacter pylori<\/italic> in Vietnam","volume":"47","author":"TT Binh","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref39","first-page":"S439","article-title":"Pattern of drug resistant <italic>Helicobacter pylori<\/italic> in dyspeptic patients in Thailand","volume":"86","author":"N Tangmankongworakoon","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1128\/JCM.41.11.5011-5014.2003","article-title":"Metronidazole-resistant <italic>Helicobacter pylori<\/italic> is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population","volume":"41","author":"SY Lui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref41","first-page":"S28","article-title":"Prevalence of single nucleotide mutation in clarithromycin resistant gene of <italic>Helicobacter pylori<\/italic>: a 32-months prospective study by using hybridization real time polymerase chain reaction","volume":"95","author":"P Hansomburana","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"ref42","first-page":"32","article-title":"Rapid detection of clarithromycin resistant <italic>Helicobacter pylori<\/italic> strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism","volume":"24","author":"S Agudo","year":"2011","journal-title":"Rev Esp Quimioter"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/hel.12031","article-title":"Prevalence of Primary and Secondary Antimicrobial Resistance of <italic>Helicobacter pylori<\/italic> in Korea from 2003 through 2012","volume":"18","author":"JW Lee","year":"2013","journal-title":"Helicobacter"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.45.3.962-965.2001","article-title":"Mutations of the <italic>Helicobacter pylori<\/italic> genes <italic>rdxA<\/italic> and <italic>pbp1<\/italic> cause resistance against metronidazole and amoxicillin","volume":"45","author":"R Paul","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2180-8-81","article-title":"Prevalence of A2143G mutation of <italic>H. pylori<\/italic>-<italic>23S rRNA<\/italic> in Chinese subjects with and without clarithromycin use history","volume":"8","author":"Z Liu","year":"2008","journal-title":"BMC Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/AAC.49.4.1600-1603.2005","article-title":"Impact of clarithromycin resistance on eradication of <italic>Helicobacter pylori<\/italic> in infected adults","volume":"49","author":"JH Lee","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1128\/AAC.48.9.3567-3569.2004","article-title":"T2182C mutation in <italic>23S rRNA<\/italic> is associated with clarithromycin resistance in <italic>Helicobacter pylori<\/italic> isolates obtained in Bangladesh","volume":"48","author":"R Khan","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/AAC.05243-11","article-title":"Distribution of spontaneous <italic>gyrA<\/italic> mutations in 97 fluoroquinolone-resistant <italic>Helicobacter pylori<\/italic> isolates collected in France","volume":"56","author":"M Garcia","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","first-page":"925","article-title":"Detection of point mutations in the <italic>gyrA<\/italic> gene of <italic>Helicobacter pylori<\/italic> isolates in Slovenia","volume":"56","author":"D Kese","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/AAC.50.4.1538-1540.2006","article-title":"Gatifloxacin resistance and mutations in gyra after unsuccessful <italic>Helicobacter pylori<\/italic> eradication in Japan","volume":"50","author":"T Nishizawa","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones","volume":"37","author":"LD Saravolatz","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T09:36:14Z","timestamp":1716975374000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101481"}},"subtitle":[],"editor":[{"given":"Herman","family":"Tse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101481","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]}}}